Community Oncology Services Global Market Expected to Reach $89.48 Billion at a CAGR of 10.4% By 2028 | GenesisCare, CStone Pharma, Pierre Fabre Group, Celnova Pharma, Tawam Hospital

The Community Oncology Services by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Community Oncology Services Market:
https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

According to The Business Research Company’s Community Oncology Services, the community oncology services market size has grown rapidly in recent years. It will grow from $53.79 billion in 2023 to $60.31 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased healthcare expenditure, rapid growth in elderly population, and health insurance reforms.

The community oncology services market size is expected to see rapid growth in the next few years. It will grow to $89.48 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increased healthcare expenditure, rapid growth in elderly population, and health insurance reforms. Major trends in the forecast period include focus on focus on providing telehealth services, increasing investments, partnerships and collaborations, developing individualized service plans, technological advancements, mergers and acquisitions.

The lower-cost care in community oncology centers is anticipated to boost the demand for the community oncology service market. The cancer care services are considered to be cost-effective in community oncology centers as compared to hospitals. According to the Community Oncology Alliance’s report published, the cost of cancer care per patient per month for various tumors in community-based clinics (CCs) was approximately $12,000 whereas the cost of cancer care in hospital-based oncology clinics (HCs) was about $20,000. Furthermore, the cost per patient per month for treatment of chemotherapy in a community setting was nearly $5,000 compared to around $8,500 in hospital-based clinics. Hence, the low cost of community oncology settings or community oncology centers are expected to drive the demand for the growth of the community oncology services market over the forecast years.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3369&type=smp

The community oncology services market covered in this report is segmented –
1) By Type: Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics
2) By Cancer Type: Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types
3) By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies

Major companies are undergoing various acquisitions and research collaborations in the community oncology services market to expand their services and offerings, which is gaining significant popularity over recent years. For instance, in April 2023, TPG, a US-based private equity company, and AmerisourceBergen Corporation, a US-based wholesale company acquired OneOncology for 2.1 billion. With this acquisition, TPG and AmerisourceBergen strengthen their presence in the specialty practice network and expand their solutions in the oncology space. OneOncology is a US-based company that focuses on transforming the patient experience and solving the pressures facing community oncology while remaining at the forefront of cancer care.

The community oncology services market report table of contents includes:
1. Executive Summary